Etodolac and Gastroenteritis - a phase IV clinical study of FDA data

Summary:

Gastroenteritis is reported as a side effect among people who take Etodolac (etodolac), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Prednisolone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Gastroenteritis when taking Etodolac. It is created by eHealthMe based on reports of 8,707 people who have side effects when taking Etodolac from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Gastroenteritis?

Gastroenteritis (inflammation of stomach and intestine) is found to be associated with 1,364 drugs and 1,278 conditions by eHealthMe. Check the latest studies of Gastroenteritis.

On Jul, 12, 2026

8,707 people reported to have side effects when taking Etodolac.
Among them, 22 people (0.25%) have Gastroenteritis.

Among these 22 people:

How long have people been on Etodolac when they have Gastroenteritis? *

What is the gender of people who have Gastroenteritis when taking Etodolac? *

female: 80.95 %
male: 19.05 %

What is the age of people who have Gastroenteritis when taking Etodolac? *

What are other drugs people take besides Etodolac? *

Prednisolone: 9 people, 40.91%
Remicade: 6 people, 27.27%
Atarax: 5 people, 22.73%
Clonazepam: 5 people, 22.73%
Neoral: 5 people, 22.73%
Dexchlorpheniramine Maleate: 5 people, 22.73%
Zyrtec: 5 people, 22.73%
Kenalog: 5 people, 22.73%
Xalatan: 5 people, 22.73%
Prednisone: 4 people, 18.18%

What are other side effects people have besides Gastroenteritis? *

Infusion Related Reaction: 5 people, 22.73%
Upper Respiratory Tract Inflammation: 5 people, 22.73%
Angiopathy (generic term for a disease of the blood vessels): 5 people, 22.73%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 22.73%
Anaemia (lack of blood): 4 people, 18.18%
Nausea And Vomiting: 4 people, 18.18%
Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 3 people, 13.64%
Chest Pain: 2 people, 9.09%
Drug Hypersensitivity: 2 people, 9.09%
Abdominal Pain: 2 people, 9.09%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 36.36%
Gastritis (inflammation of stomach): 7 people, 31.82%
Behcet's Syndrome (involves inflammation of the blood vessels): 5 people, 22.73%
Sinusitis (inflammation of sinus): 5 people, 22.73%
Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 22.73%
Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 5 people, 22.73%
High Blood Pressure: 3 people, 13.64%
Upper Respiratory Tract Inflammation: 3 people, 13.64%
Ingrowing Nail: 3 people, 13.64%
Ventricular Extrasystoles (premature cardiac contraction): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and have Gastroenteritis?

- Check whether Gastroenteritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etodolac:

Etodolac (9,157 reports)

Gastroenteritis treatments and more:

Gastroenteritis (21,518 reports)

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastroenteritis:

Gastroenteritis (1,364 drugs)

Browse all the conditions that are associated with Gastroenteritis:

Gastroenteritis (1,278 conditions)

Related publications that referenced our studies

Liao KF, Cheng KC, Lin CL, Lai SW, "Etodolac and the risk of acute pancreatitis", BioMedicine, 2017 Jan .
Liao KF, Cheng KC, Lin CL, Lai SW, "Etodolac and the risk of acute pancreatitis", BioMedicine, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on etodolac (the active ingredients of Etodolac) and Etodolac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.